<DOC>
	<DOCNO>NCT01278199</DOCNO>
	<brief_summary>Severe hemoptysis life-threatening condition , unpredictable course . The efficacy bronchial artery embolization ( BAE ) well establish treatment severe hemoptysis , short long-term bleeding control obtain 70 100 % 50 90 % case , respectively . As complication related vascular interventional radiology may occur 5 10 % case , benefit-risk balance might less clear acute hemoptysis mild-to-moderate abundance ( volume 100 200 ml ) criterion severity ( respiratory failure hemodynamic instability ) . There available data compare safety efficacy BAE combine medical measure medical measure alone treatment non-severe acute hemoptysis mild-to-moderate abundance .</brief_summary>
	<brief_title>Bronchial Artery Embolization Medical Measures Non Severe Acute Hemoptysis Mild-moderate Abundance</brief_title>
	<detailed_description>The study multicentric ( n=8 ) randomize study , involve two parallel group patient non-severe acute hemoptysis mild-to-moderate abundance , related systemic bronchial non-bronchial hypervascularization , compare bronchial artery embolization combine medical measure medical measure alone field . The primary aim study evaluate efficacy BAE combine medical measure treatment non-severe acute hemoptysis mild-to-moderate abundance , compare medical measure alone , assess percentage recurrence hemoptysis one month . Bleeding recurrence define volume blood expectorate least 50 ml . The second objective study compare efficacy two strategy 3 month assess safety strategy hospitalization follow-up . Based previous study group ( Reference 8 ) , number patient group 105 , assume one-month bleeding recurrence rate 11 % group receive BAE , compare 26 % group assist medically ( a=.05 ; Î²=0.8 ) .</detailed_description>
	<mesh_term>Hemoptysis</mesh_term>
	<mesh_term>Acute Disease</mesh_term>
	<criteria>Nonsevere acute hemoptysis ( mildtomoderate abundance criterion severity ) . Age &gt; 18 year Patients social insurance Pregnant and/or lactate woman Traumatic hemoptysis Severe hemoptysis ( volume &gt; 200 ml ; respiratory failure ; hemodynamic instability ) Patients already enrol study within precede 3 month Patients palliative care , therapeutic plan shortterm Moribund patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bronchial Artery Embolization</keyword>
	<keyword>Non-severe Hemoptysis</keyword>
	<keyword>Bleeding mild-to-moderate abundance</keyword>
	<keyword>Volume range 100 ml 200 ml</keyword>
</DOC>